Gu, J., Zhang, Y., Han, Z., Gao, L., Cui, J., Sun, Y., . . . Yeh, S. (2020). Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Cell Death Dis.
Citação norma ChicagoGu, Junfei, et al. "Targeting the ERβ/Angiopoietin-2/Tie-2 Signaling-mediated Angiogenesis With the FDA-approved Anti-estrogen Faslodex to Increase the Sunitinib Sensitivity in RCC." Cell Death Dis 2020.
MLA citiranjeGu, Junfei, et al. "Targeting the ERβ/Angiopoietin-2/Tie-2 Signaling-mediated Angiogenesis With the FDA-approved Anti-estrogen Faslodex to Increase the Sunitinib Sensitivity in RCC." Cell Death Dis 2020.
Opozorilo: Ti citati niso vedno 100% točni.